Bionomics Limited (Nasdaq: BNOX, ASX: BNO) to Ring the Nasdaq Stock Market Closing Bell on Friday January 14, 2022

Rhea-AI Summary

Bionomics Limited (Nasdaq: BNOX, ASX: BNO) will ring the Nasdaq Closing Bell remotely on January 14, 2022. The ceremony will feature Dr Errol De Souza, Executive Chairman, and the company team. The live stream can be accessed through the Nasdaq website. Bionomics is focused on developing allosteric ion channel modulators for central nervous system disorders, with its lead candidate, BNC210, targeting Social Anxiety Disorder and PTSD. The company has a partnership with Merck for cognitive treatment trials in Alzheimer's disease.

Positive

• Bionomics is developing innovative treatments for serious CNS disorders.
• The company's lead candidate, BNC210, is aimed at treating Social Anxiety Disorder and PTSD.
• Bionomics has a strategic partnership with Merck for cognitive deficit treatments.

Negative

• None.

EASTWOOD, Australia, Jan. 14, 2022 /PRNewswire/ -- Bionomics Limited (Nasdaq: BNOX, ASX: BNO), a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders with high unmet medical need, will ring the Nasdaq Closing Bell remotely from around the globe.

Dr Errol De Souza, Executive Chairman, will ring the Closing Bell alongside the Company's team in a virtual bell ringing ceremony.

When:
FRIDAY, JANUARY 14, 2021 – 3:45 p.m. to 4:00 p.m. ET 

Webcast:
A live stream of the Nasdaq Closing Bell will be available at: https://www.nasdaq.com/marketsite/bell-ringing-ceremony  

Social Media:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies, please visit our Facebook page: http://www.facebook.com/nasdaq. 

For photos from ceremonies and events, please visit our Instagram page: http://instagram.com/nasdaq

Photos:
To obtain a hi-resolution photograph of the Market Close, please go to https://www.nasdaq.com/marketsite/bell-ringing-ceremony  and click on the market close of your choice.

FOR FURTHER INFORMATION PLEASE CONTACT:

General: Ms Suzanne Irwin Company Secretary +61 8 8150 7400 CoSec@bionomics.com.au

Investor Relations: Mr. Connor Bernstein Vice President, Strategy and Corporate Development +1 (831) 246 3642 cbernstein@bionomics.com.au

About Bionomics Limited:
Bionomics (Nasdaq: BNOX, ASX:BNO) is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders with high unmet medical need. Bionomics is advancing its lead product candidate, BNC210, an oral, proprietary, selective negative allosteric modulator of the α7 nicotinic acetylcholine receptor, for the acute treatment of Social Anxiety Disorder and chronic treatment of Post-Traumatic Stress Disorder. Beyond BNC210, Bionomics has a strategic partnership with Merck & Co., Inc. (known as MSD outside the United States and Canada) with two drugs in early-stage clinical trials for the treatment of cognitive deficits in Alzheimer's disease and other central nervous system conditions.  To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Bionomics1, or at www.bionomics.com.au.

About Nasdaq:
Nasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.

View original content:https://www.prnewswire.com/news-releases/bionomics-limited-nasdaq-bnox-asx-bno-to-ring-the-nasdaq-stock-market-closing-bell-on-friday-january-14-2022-301461190.html

SOURCE Bionomics Limited

FAQ

When is Bionomics Limited ringing the Nasdaq Closing Bell?

Bionomics Limited will ring the Nasdaq Closing Bell on January 14, 2022.

Who will ring the Nasdaq Closing Bell for Bionomics Limited?

Dr Errol De Souza, Executive Chairman, will ring the Closing Bell.

What is the significance of the Nasdaq Closing Bell for Bionomics Limited?

Ringing the Nasdaq Closing Bell highlights Bionomics' presence in the market and commitment to advancing its clinical-stage biopharmaceutical developments.

What is Bionomics Limited developing?

Bionomics is developing allosteric ion channel modulators for central nervous system disorders.

What is the lead product candidate of Bionomics Limited?

Bionomics' lead product candidate is BNC210, targeting Social Anxiety Disorder and PTSD.